Integer Holdings Corporation

ITGR Healthcare Medical Devices

Integer Holdings Corporation’s revenue for fiscal 2025 (year ended December 2025) was $1.9 billion, up 7.98% from fiscal 2024. In the quarter to June 2026, revenue fell 2.60%, EPS fell 34.9%, free cash flow grew 48.8% and total debt rose 4.96%, each against the same quarter a year earlier. Revenue growth for five consecutive years; insiders bought in the last twelve months.

126.70 0.02 −0.02%
Market cap
$4.3B
P/E
34.3×
Fwd P/E
27.6×
Dividend yield
—
F-score
6/9
Altman Z
2.34
Beneish M
−2.30
Dividend safety
n/a
Jun '26 Mar '26 Dec '25 Sep '25 Older periods
P/E ratio
25.33 21.67 26.86 41.33

+8 more quarters

P/S ratio
1.72 1.63 1.47 1.98
P/FCF ratio
28.64 30.52 26.17 30.13
P/Operating CF
53.21 122.15 49.16 55.26
P/B ratio
1.85 1.78 1.56 2.08
EV/Sales
2.41 2.32 2.12 2.61
EV/EBITDA
13.75 12.46 10.93 13.56
EV/FCF
40.06 43.63 37.66 39.77
Current Ratio
3.73 3.75 3.32 3.71
Net Debt/EBITDA
17.93 18.92 12.85 12.74
Debt/Equity
0.75 0.77 0.69 0.70
Earnings Yield
3.95% 4.61% 3.72% 2.42%
Free Cash Flow Yield
3.49% 3.28% 3.82% 3.32%
Free Cash Flow per Share
1.09 0.02 0.80 1.32
Book value per Share
50.54 49.50 50.28 49.77
Free Cash Flow
36.99 0.79 27.94 46.26
EV/EBIT
24.87 21.18 17.72 21.52
Other line items

Show all line items

Columns are period end dates